Table 3 Psychiatric diagnostic categories and psychotropic medication use among participants.
Patient number | Age (yr) | Gender | Diagnosis (DSM-5-TR–based classification) | Psychotropic medication use (/day) |
|---|---|---|---|---|
1 | 53 | Male | Neurodevelopmental disorders, depressive disorders | sodium valproate (fine granules 40%) 2 g, diazepam 4 mg, eszopiclone 2 mg, suvorexant 15 mg |
2 | 43 | Male | Schizophrenia spectrum and other psychotic disorders | haloperidol 3 mg, escitalopram 20 mg、alprazolam 0.8 mg、lemborexant 2.5 mg |
3 | 38 | Female | Anxiety disorders | quetiapine 100 mg, mirtazapine 45 mg, sodium valproate (fine granules 40%) 1 g, cloxazolam 2 mg, bezafibrate 400 mg |
4 | 73 | Female | Somatic symptom and related disorders, suspected neurocognitive disorders | quetiapine 100 mg, clonazepam 0.5 mg, lemborexant 2.5 mg |
5 | 50 | Male | Schizophrenia spectrum and other psychotic disorders, neurodevelopmental disorders, sleep-wake disorders, feeding and eating disorders | lurasidone 60 mg, trazodone 50 mg, guanfacine 6 mg, sodium valproate 1000 mg, topiramate 75 mg, carbamazepine 200 mg, clonazepam 0.5 mg, lemborexant 10 mg |
6 | 53 | Male | Schizophrenia spectrum and other psychotic disorders | perospirone 48 mg, brexpiprazole 2 mg, bromazepam 2 mg, suvorexant 20 mg, eszopiclone 3 mg |
7 | 44 | Female | Depressive disorders | sertraline 150 mg, flunitrazepam 2 mg, lorazepam 1 mg, suvorexant 20 mg |
8 | 90 | Male | Schizophrenia spectrum and other psychotic disorders, neurocognitive disorders | risperidone 1.5 mg, lemborexant 5 mg |
9 | 63 | Female | Depressive disorders, trauma- and stressor-related disorders | quetiapine 62.5 mg, duloxetine 60 mg, clonazepam 2 mg, lemborexant 2.5 mg |
10 | 48 | Male | Schizophrenia spectrum and other psychotic disorders, depressive disorders | paliperidone 6 mg, aripiprazole 12 mg, sodium valproate 600 mg, nitrazepam 10 mg, zolpidem 5 mg, lemborexant 2.5 mg |
11 | 71 | Female | Schizophrenia spectrum and other psychotic disorders | haloperidol 9 mg |
12 | 27 | Male | Bipolar and related disorders | sulpiride 50 mg, fluvoxamine 50 mg, sodium valproate 600 mg, bromazepam 2 mg |
13 | 55 | Female | Schizophrenia spectrum and other psychotic disorders | blonanserin (tape) 20 mg |
14 | 76 | Male | Schizophrenia spectrum and other psychotic disorders | quetiapine 75 mg |
15 | 60 | Female | Schizophrenia spectrum and other psychotic disorders | blonanserin (tape) 40 mg |
16 | 63 | Male | Schizophrenia spectrum and other psychotic disorders, neurodevelopmental disorders, neurocognitive disorders | lithium carbonate 200 mg, valproate (as sodium valproate) 800 mg, suvorexant 15 mg |
17 | 88 | Female | Depressive disorders | duloxetine 20 mg, lemborexant 5 mg |
18 | 26 | Male | Depressive disorders | mianserin 20 mg, bromazepam 10 mg, flunitrazepam 2 mg |
19 | 80 | Female | Depressive disorders | levomepromazine 20 mg, paroxetine 25 mg, flunitrazepam 2 mg, bromazepam 4 mg, zolpidem 10 mg |
20 | 55 | Male | Schizophrenia spectrum and other psychotic disorders | blonanserin 24 mg, diazepam 15 mg, lemborexant 10 mg |
21 | 35 | Female | Schizophrenia spectrum and other psychotic disorders | aripiprazole 3 mg |
22 | 65 | Male | Substance-related and addictive disorders, sleep-wake disorders | trazodone 50 mg, lemborexant 10 mg |
